Bone marrow derived cells in tumor angiogenesis and growth: are they the good, the bad or the evil?

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1796, Issue 1, 2009, Pages 1-4

  Shaked, Yuval ^a   Voest, Emile E ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; CD11B ANTIGEN; CD45 ANTIGEN; FLUOROURACIL; FOLINIC ACID; GROWTH FACTOR; MONOCLONAL ANTIBODY DC101; OXALIPLATIN; SORAFENIB; STROMAL CELL DERIVED FACTOR 1; SUNITINIB; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 1;

ADJUVANT THERAPY; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ANTIGEN EXPRESSION; BONE MARROW CELL; BREAST CANCER; CANCER SURVIVAL; CAPILLARY; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE MARKER; DRUG MECHANISM; DRUG TREATMENT FAILURE; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; KIDNEY CANCER; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MESENCHYMAL STEM CELL; METASTASIS; MOLECULAR MECHANICS; NONHUMAN; PANCREAS TUMOR; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STEM CELL; TUMOR CELL; TUMOR GROWTH; TUMOR RESISTANCE; TUMOR VASCULARIZATION; UPREGULATION;

ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; ENDOTHELIAL CELLS; HEMANGIOBLASTS; HUMANS; MYELOID CELLS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 68949155165     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2009.07.002     Document Type: Review

References (46)

1. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., and Isner J.M. Circ. Res. 85 (1999) 221
2. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., and Isner J.M. Science 275 (1997) 964
3. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., Inai Y., Silver M., and Isner J.M. EMBO J. 18 (1999) 3964
4. Berenson A. New York Times (2006)
5. Bergers G., and Hanahan D. Nat. Rev. Cancer 8 (2008) 592
6. Bertolini F., Shaked Y., Mancuso P., and Kerbel R.S. Nat. Rev. Cancer 6 (2006) 835
7. Conejo-Garcia J.R., Buckanovich R.J., Benencia F., Courreges M.C., Rubin S.C., Carroll R.G., and Coukos G. Blood 105 (2005) 679
8. De Palma M., Venneri M.A., Galli R., Sergi L.S., Politi L.S., Sampaolesi M., and Naldini L. Cancer Cell 8 (2005) 211
9. Ebos J.M., Lee C.R., Cruz-Munoz W., Bjarnason G.A., Christensen J.G., and Kerbel R.S. Cancer Cell 15 (2009) 232
10. Escudier B., Eisen T., Stadler W.M., Szczylik C., Oudard S., Siebels M., Negrier S., Chevreau C., Solska E., Desai A.A., Rolland F., Demkow T., Hutson T.E., Gore M., Freeman S., Schwartz B., Shan M., Simantov R., and Bukowski R.M. N. Engl. J. Med. 356 (2007) 125
11. Gabrilovich D. Nat. Rev. Immunol. 4 (2004) 941
12. Gao D., Nolan D.J., Mellick A.S., Bambino K., McDonnell K., and Mittal V. Science 319 (2008) 195
13. Gothert J.R., Gustin S.E., Van Eekelen A.M., Schmidt U., Hall M.A., Jane S.M., Green A.R., Gottgens B., Izon D.J., and Begley C.G. Blood 104 (2004) 1769
14. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Yung S., Chimenti S., Landsman L., Abramovitch R., and Keshet E. Cell 124 (2006) 175
15. Heil M., Ziegelhoeffer T., Mees B., and Schaper W. Circ. Res. 94 (2004) 573
16. Horrevoets A.J. Am. J. Pathol. 174 (2009) 1594
17. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth H., Helm W., Berlin J., Baron A., Griffing S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross R., and Kabbinavar F. N. Engl. J. Med. 350 (2004) 2335
18. Jin D.K., Shido K., Kopp H.G., Petit I., Shmelkov S.V., Young L.M., Hooper A.T., Amano H., Avecilla S.T., Heissig B., Hattori K., Zhang F., Hicklin D.J., Wu Y., Zhu Z., Dunn A., Salari H., Werb Z., Hackett N.R., Crystal R.G., Lyden D., and Rafii S. Nat. Med. 12 (2006) 557
19. Kaplan R.N., Psaila B., and Lyden D. Trends. Mol. Med. 13 (2007) 72
20. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., MacDonald D.D., Jin D.K., Shido K., Kerns S.A., Zhu Z., Hicklin D., Wu Y., Port J.L., Altorki N., Port E.R., Ruggero D., Shmelkov S.V., Jensen K.K., Rafii S., and Lyden D. Nature 438 (2005) 820
21. Kerbel R.S. Science 312 (2006) 1171
22. Kerbel R.S. N. Engl. J. Med. 358 (2008) 2039
23. Kerbel R.S., Benezra R., Lyden D.C., Hattori K., Heissig B., Nolan D.J., Mittal V., Shaked Y., Dias S., Bertolini F., and Rafii S. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) E54
24. Kim S.J., Kim J.S., Papadopoulos J., Wook K.S., Maya M., Zhang F., He J., Fan D., Langley R., and Fidler I.J. Am. J. Pathol. 174 (2009) 1972
25. Llovet J., Ricci S., Mazzaferro V., Hilgard P., Raoul J., Zeuzem S., Poulin-Costello M., Moscovici M., Voliotis D., Bruix J., and for the SHARP investigators study group. Sorafenib Improves Survival in Advanced Hepatocellular Carcinoma (HCC): Results of a Phase III Randomized Placebo-Controlled Trial (SHARP Trial) (2007) Abstract no. LBA1
26. Loges S., Mazzone M., Hohensinner P., and Carmeliet P. Cancer Cell 15 (2009) 167
27. Machein M.R., Renninger S., Lima-Hahn E., and Plate K.H. Brain Pathol. 13 (2003) 582
28. Miller K., Wang M., Gralow J., Dickler M., Cobleigh M., Perez E.A., Shenkier T., Cella D., and Davidson N.E. N. Engl. J. Med. 357 (2007) 2666
29. Nozawa H., Chiu C., and Hanahan D. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 12493
30. Paez-Ribes M., Allen E., Hudock J., Takeda T., Okuyama H., Vinals F., Inoue M., Bergers G., Hanahan D., and Casanovas O. Cancer Cell 15 (2009) 220
31. Peters B.A., Diaz L.A., Polyak K., Meszler L., Romans K., Guinan E.C., Antin J.H., Myerson D., Hamilton S.R., Vogelstein B., Kinzler K.W., and Lengauer C. Nat. Med. 11 (2005) 261
32. Petit I., Jin D., and Rafii S. Trends. Immunol. 28 (2007) 299
33. Purhonen S., Palm J., Rossi D., Kaskenpaa N., Rajantie I., Yla-Herttuala S., Alitalo K., Weissman I.L., and Salven P. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 6620
34. Rajantie I., Ilmonen M., Alminaite A., Ozerdem U., Alitalo K., and Salven P. Blood 104 (2004) 2084
35. Ribatti D., Nico B., Crivellato E., and Vacca A. Leukemia 21 (2007) 2085
36. Rini B.I. Clin. Cancer Res. 13 (2007) 1098
37. Sandler A., Gray R., Perry M.C., Brahmer J., Schiller J.H., Dowlati A., Lilenbaum R., and Johnson D.H. N. Engl. J. Med. 355 (2006) 2542
38. Shaked Y., Ciarrocchi A., Franco M., Lee C.R., Man S., Cheung A.M., Hicklin D.J., Chaplin D., Foster F.S., Benezra R., and Kerbel R.S. Science 313 (2006) 1785
39. Shaked Y., Henke E., Roodhart J.M., Mancuso P., Langenberg M.H., Colleoni M., Daenen L.G., Man S., Xu P., Emmenegger U., Tang T., Zhu Z., Witte L., Strieter R.M., Bertolini F., Voest E.E., Benezra R., and Kerbel R.S. Cancer Cell 14 (2008) 263
40. Shaked Y., and Kerbel R.S. Cancer Res. 67 (2007) 7055
41. Shojaei F., and Ferrara N. Cancer Res. 68 (2008) 5501
42. Shojaei F., Wu X., Malik A.K., Zhong C., Baldwin M.E., Schanz S., Fuh G., Gerber H.P., and Ferrara N. Nat. Biotechnol. 25 (2007) 911
43. Stockmann C., Doedens A., Weidemann A., Zhang N., Takeda N., Greenberg J.I., Cheresh D.A., and Johnson R.S. Nature 456 (2008) 814
44. Udagawa T., Puder M., Wood M., Schaefer B.C., and D'Amato R.J. FASEB J. 20 (2006) 95
45. Wolmark N., Yothers G., O'Connell M.J., Sharif S., Atkins J.N., Seay T.E., Fehrenbacher L., and O'Reilly S. J. Clin. Oncol. 27 (2009)
46. Yang L., DeBusk L.M., Fukuda K., Fingleton B., Green-Jarvis B., Shyr Y., Matrisian L.M., Carbone D.P., and Lin P.C. Cancer Cell 6 (2004) 409